Bioactive lipids and vascular disease
- PMID: 34131297
- DOI: 10.1038/s41430-021-00925-2
Bioactive lipids and vascular disease
References
-
- Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Ess Fat Acids. 1995;52:387–91. - DOI
-
- Das UN. A defect in the activity of D6 and D5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Ess Fat Acids. 2005;72:343–50. - DOI
-
- Gromovsky AD, Schugar RC, Brown AL, Helsley RN, Burrows AC, Ferguson D, et al. Δ-5 fatty acid desaturase FADS1 impacts metabolic disease by balancing proinflammatory and proresolving lipid mediators. Arterioscler Thromb Vasc Biol. 2018;38:218–31. https://doi.org/10.1161/ATVBAHA.117.309660 . Epub 2017 Oct 26. - DOI - PubMed
-
- Krishna Mohan I, Das UN. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition. 2001;17:126–51. https://doi.org/10.1016/s0899-9007(00)00468-8 . - DOI - PubMed
-
- Suresh Y, Das UN. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Ess Fat Acids. 2001;64:37–52. https://doi.org/10.1054/plef.2000.0236 . - DOI